Bristlecone Advisors, LLC Zoetis Inc. Transaction History

Bristlecone Advisors, LLC

$1.17 Billion
Q3 2025

A detailed history of Bristlecone Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 14,658 shares of ZTS stock, worth $1.75 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

14,658

Previous 15,362 4.58%

Holding current value

$1.75 Million

Previous $2.4 Million 10.48%

% of portfolio

0.18%

Previous 0.2%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$141.13 - $159.19 $99,355 - $112,069	-704 Reduced 4.58%	14,658 $2.14 Million
Q2 2025 Aug 04, 2025	SELL	$144.41 - $170.3 $77,836 - $91,791	-539 Reduced 3.39%	15,362 $2.4 Million
Q1 2025 May 12, 2025	SELL	$156.48 - $175.67 $33,799 - $37,944	-216 Reduced 1.34%	15,901 $2.62 Million
Q4 2024 Jan 29, 2025	SELL	$162.24 - $194.42 $56,946 - $68,241	-351 Reduced 2.13%	16,117 $2.63 Million
Q3 2024 Oct 24, 2024	SELL	$172.58 - $196.48 $3,624 - $4,126	-21 Reduced 0.13%	16,468 $3.22 Million
Q2 2024 Jul 25, 2024	SELL	$145.54 - $178.83 $85,723 - $105,330	-589 Reduced 3.45%	16,489 $2.86 Million
Q1 2024 Apr 22, 2024	SELL	$165.67 - $199.94 $28,329 - $34,189	-171 Reduced 0.99%	17,078 $2.89 Million
Q4 2023 Jan 25, 2024	SELL	$151.44 - $200.09 $28,773 - $38,017	-190 Reduced 1.09%	17,249 $3.4 Million
Q3 2023 Oct 16, 2023	BUY	$167.14 - $192.77 $117,666 - $135,710	704 Added 4.21%	17,439 $3.03 Million
Q2 2023 Aug 03, 2023	SELL	$160.94 - $186.23 $116,359 - $134,644	-723 Reduced 4.14%	16,735 $2.88 Million
Q1 2023 May 11, 2023	SELL	$145.48 - $175.02 $14,984 - $18,027	-103 Reduced 0.59%	17,458 $2.91 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $39,604 - $47,555	-302 Reduced 1.69%	17,561 $2.57 Million
Q3 2022 Oct 27, 2022	BUY	$148.29 - $182.55 $3,855 - $4,746	26 Added 0.15%	17,863 $2.65 Million
Q2 2022 Jul 25, 2022	BUY	$155.97 - $200.09 $10,138 - $13,005	65 Added 0.37%	17,837 $3.07 Million
Q1 2022 Apr 22, 2022	SELL	$181.39 - $234.03 $59,314 - $76,527	-327 Reduced 1.81%	17,772 $3.35 Million
Q4 2021 Jan 19, 2022	SELL	$193.69 - $247.03 $379,632 - $484,178	-1,960 Reduced 9.77%	18,099 $4.42 Million
Q3 2021 Oct 19, 2021	SELL	$189.29 - $209.69 $60,572 - $67,100	-320 Reduced 1.57%	20,059 $3.89 Million
Q2 2021 Jul 21, 2021	SELL	$155.9 - $187.99 $43,807 - $52,825	-281 Reduced 1.36%	20,379 $3.8 Million
Q1 2021 Apr 30, 2021	SELL	$144.0 - $169.39 $38,448 - $45,227	-267 Reduced 1.28%	20,660 $3.25 Million
Q4 2020 Jan 25, 2021	BUY	$157.07 - $174.35 $8,167 - $9,066	52 Added 0.25%	20,927 $3.46 Million
Q3 2020 Oct 20, 2020	SELL	$137.1 - $165.37 $315,604 - $380,681	-2,302 Reduced 9.93%	20,875 $3.45 Million
Q2 2020 Jul 16, 2020	BUY	$111.92 - $142.53 $168,215 - $214,222	1,503 Added 6.93%	23,177 $3.18 Million
Q1 2020 Apr 16, 2020	BUY	$92.66 - $144.94 $49,387 - $77,253	533 Added 2.52%	21,674 $2.55 Million
Q4 2019 Jan 21, 2020	BUY	$116.25 - $133.25 $99,975 - $114,595	860 Added 4.24%	21,141 $2.8 Million
Q3 2019 Oct 28, 2019	SELL	$112.57 - $128.43 $62,476 - $71,278	-555 Reduced 2.66%	20,281 $2.53 Million
Q2 2019 Jul 19, 2019	BUY	$97.98 - $114.28 $151,379 - $176,562	1,545 Added 8.01%	20,836 $2.37 Million
Q1 2019 Apr 23, 2019	BUY	$81.56 - $100.67 $17,127 - $21,140	210 Added 1.1%	19,291 $1.94 Million
Q4 2018 Jan 15, 2019	SELL	$79.28 - $95.27 $7,531 - $9,050	-95 Reduced 0.5%	19,081 $1.63 Million
Q3 2018 Oct 22, 2018	BUY	$83.5 - $93.23 $660,902 - $737,915	7,915 Added 70.29%	19,176 $1.76 Million
Q2 2018 Jul 31, 2018	BUY	$79.9 - $89.2 $37,153 - $41,478	465 Added 4.31%	11,261 $959,000
Q1 2018 Apr 24, 2018	SELL	$71.51 - $84.69 $187,356 - $221,887	-2,620 Reduced 19.53%	10,796 $902,000
Q4 2017 Jan 30, 2018	BUY	$63.24 - $72.8 $845,835 - $973,700	13,375 Added 32621.95%	13,416 $966,000
Q3 2017 Oct 20, 2017	BUY	$59.73 - $65.4 $2,448 - $2,681	41	41 $3,000

Others Institutions Holding ZTS

# of Institutions

2,117

Shares Held

432M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $56B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Zoetis Inc. Transaction History